WHC is still in active development. Read this to understand our approach.
depiction of DMULVCHRPCFFGV-UHFFFAOYSA-N.svg
tripsit

dmt

Check on tripsit

psychonaut

DMT

Check on psychonaut

isomerdesign

DMT

Check on isomerdesign

pubchem

N,N-Dimethyltryptami...

Check on pubchem

druglab

DMT

Check on druglab

drugmap

2-(1H-indol-3-yl)-N,...

Check on drugmap

Data

InChI: InChI=1S/C12H16N2/c1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12/h3-6,9,13H,7-8H2,1-2H3

Synonyms: 061D507,Dimethyltryptamine(DMT),C08302,2-(1H-INDOL-3-YL)-N,N-DIMETHYL-ETHANAMINE,CHEBI:28969,GTPL141,HSDB 8017,DTXSID60110053, 2-(3-Indolyl)ethyldimethylamine,3-[2-(Dimethylamino)ethyl]indole,N,N-dimethyl-1H-Indole-3-ethanamine (9CI),DIMETHYLTRYPTAMINE [MART.],Desoxybufotenine,NSC63795,EINECS 200-508-4,[2-(1H-indol-3-yl)ethyl]dimethylamine,1H-Indole-3-ethanamine, N,N-dimethyl-,ZINC897457, 61-50-7, EINECS 200-508-4, 1H-Indole-3-ethanamine, N,N-dimethyl-,AKOS005446117,3-[2- (dimethylamino)ethyl]-Indole,2-(1H-Indol-3-yl)-N,N-dimethylethanamine,MFCD00055989,Nigerine,NSC 63795,dimethyltryptamine,3-(2-(dimethylamino)ethyl)-Indole,3-(2-Dimethylaminoethyl)indole, WUB601BHAA,2-(1H-Indol-3-yl)-N,N-dimethyl-ethanamine,3-[2-(dimethylamino)ethyl]indole,2-(1H-indol-3-yl)-ethyl-dimethyl-amine,1H-INDOLE-3-ETHANAMINE,N,N-DIMETHYL,[2-(1H-INDOL-3-YL)-ETHYL]-DIMETHYL-AMINE,2-(3-Indolyl)ethyldimethylamine,Q407217,WLN: T56 BMJ D2N1&1,NSC-63795, 2-(1H-Indol-3-yl)-N,N-dimethylethanamine,BRN 0138259,NN-Dimethyltryptamine,Indole, 3-(2-(dimethylamino)ethyl)-,Indolalkylamine der, BRN 0138259, DMT (psychogenic), CHEMBL12420,CHEMBL12420,N,N-Dimethyltryptamine,Indole, 3-[2-(dimethylamino)ethyl],DMT,N,N-Dimethyltryptamine, free base,N,N-Dimethyltryptamine, >=97% (HPLC),AS-47089,N,N-DIMETHYLTRYPTAMINE,N,N-Dimethyltryptamine (DMT) solution, 1.0 mg/mL in methanol, certified reference material,N,N-DIMETHYLTRYPTAMINE [MI],L001288,N-DIMETHYLTRYPTAMINE,2-(1H-indol-3-yl)-N,N-dimethylethylamine, NSC 63795,DB01488, UNII-WUB601BHAA, 3-[2-(dimethylamino)ethyl]indole, DIMETHYLTRYPTAMINE,UNII-WUB601BHAA,61-50-7,BDBM50026868,D-5500,DEA No. 7435,Tryptamine, N,N-dimethyl,2-(1H-indol-3-yl)-N,N-dimethylethanamine (ACD/Name 4.0), N,N-DIMETHYLTRYPTAMINE, DMULVCHRPCFFGV-UHFFFAOYSA-N,3-(dimethylaminoethyl)-indole,STK370594, CHEBI:28969,MB00483, (2-Indol-3-ylethyl)dimethylamine, Dimethyltryptamine,DIMETHYLTRYPTAMINE [WHO-DD],N,N-dimethyl-1H-Indole-3-ethanamine, (psychogenic),(N,N)-Dimethyltryptamine, DEA No 7435,WUB601BHAA,N-(2-(1H-indol-3-yl)ethyl)-N,N-dimethylamine (ACD/Name 4.0),3-(2-DIMETHYLAMINOETHYL) INDOLE, N,N-dimethyl-1H-Indole-3-ethanamine,3-(2-(DIMETHYLAMINO)ETHYL)INDOLE,N,N-Dimethyl-1H-indole-3-ethylamine,(2-Indol-3-ylethyl)dimethylamine,SCHEMBL335710,DMT (psychogenic), Indole,,DIMETHYLTRYPTAMINE,n,n-dmt,Indole, 3-[2-(dimethylamino)ethyl]-, N,N-Dimethyl-1H-indole-3-ethylamine,(psychogenic), 3-(2-Dimethylaminoethyl)indole,2-(1H-Indol-3-yl)-N,N-dimethylethanamine #,1H-Indole-3-ethanamine,N,N-dimethyl-

Estimated data

Solubility: -1.459 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 94.2% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.